AdjuTec Pharma leads €2.2M Eurostars project to combat deadly lung infections


28 augusti, 08:54

AdjuTec Pharma has signed a €2.2 million Eurostars consortium agreement, spearheading an international effort to combat multidrug-resistant lung infections. The three-year project will unite four European partners in the search for effective new antibiotic combinations, leveraging AdjuTec’s resistance-breaking technology. BioStock reached out to CEO Jethro Holter and COO Bjørn Klem for comments.

Read the full interview at biostock.se:

https://biostock.se/en/2025/08/adjutec-pharma-leads-e2-2m-eurostars-project-to-combat-deadly-lung-infections/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!  

About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.  
BioStock – Connecting Innovation & Capital. 

Läs mer på BioStock

Marknadsöversikt

1 DAG %

Senast

1 mån